Beijing Yikangsida Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of pharmaceutical intermediates. The company is located in Changping District, Beijing, and boasts a team of highly qualified professionals in R&D, production, and sales, along with one R&D center and two production bases. Through years of research and technological innovation, the company has mastered the production technologies for over 10 types of pharmaceutical raw materials and intermediates. Its product lines include: - Anti-cancer series: Docetaxel, Paclitaxel, Mitoxantrone Hydrochloride, Granisetron Hydrochloride, Gemcitabine Hydrochloride. - Muscle relaxant series: Vecuronium Bromide, Rocuronium Bromide, among others. Over 90% of the company's products are exported to India, Europe, the United States, South Korea, Japan, and Southeast Asia, where it has established friendly and cooperative relationships with its clients.